Axonics® Announces U.S. Food & Drug Administration Approval for its Sacral Neuromodulation System for Urinary Clinical Indications

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. SPY
4. META
5. MU
6. NVDA
7. BLZE
8. IBM
9. PRIM
10. ACN

Go back to Axonics® Announces U.S. Food & Drug Administration Approval for its Sacral Neuromodulation System for Urinary Clinical Indications
(NASDAQ: AXNX) Delayed: 70.98 --0 (-0%)
Previous Close $70.98    52 Week High $ 
Open $70.98    52 Week Low $ 
Day High $70.98    P/E N/A 
Day Low $70.98    EPS $ 
Volume 142